Home Reported Outcomes in C3G Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Home Reported Outcomes in C3G Study — Stella

Home/C3 Glomerulopathy/

View on ClinicalTrials.gov

Recruiting

Back to C3 Glomerulopathy trials

Trial locations(1 site)

United States

Novartis Investigative Site, East Hanover, New Jersey

Key details

Sponsor

Novartis Pharmaceuticals

Enrollment target

~100 participants

Started

April 2025

Primary completion

April 2026

Age range

18 Years – 100 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.